Figure 5C )
Understanding Michigan Medicaids New GLP-1 Coverage Rules In late 2025, Michigan Medicaid will implement significant restrictions on coverage for GLP-1 receptor agonists used for weight lossincluding brand-name medications such as Wegovy and Zepbound
These medications target insulin resistance and related comorbidities, but their use raises questions about safety, access and ethical considerations
Its important that you follow the instructions given to you by your prescriber during a medication transition, as they will have taken your current health and other circumstances into account when writing your prescription
Fortunately, with the right strategies, such as starting at a lower dose, switching to extended-release formulations, and making simple dietary adjustments, most people can continue taking metformin successfully
Can I take anti-sickness medication with Ozempic